Obesity medications symposium: what, why, how?
Australian/NZ dietitians: The live symposium is Wednesday, 20th November at 9.30am-12pm AEDT
US dietitians: The live symposium is Tuesday, November 19 at 5:30-8p.m. ET.
Use this time converter tool to convert the time to your location. A recording will be made available after the live event.
About the symposium:
The world of obesity medications is rapidly evolving, so we’re bringing you a half day virtual symposium featuring Dr Terri-Lynne South, Dr Jessica McMaster and Glenn Mackintosh to help you stay up-to-date with the latest science and practical applications in dietetic practice. From a doctor, a dietitian and a psychologists’ perspective, the symposium will answer all your questions about obesity medications, including:
- How do obesity medications actually work?
- What are the side effects, and how can a dietitian help?
- What are the key nutrients to consider?
- How can you support behavioural change in these patients?
- What are the long-term implications?
Mark your diary for Wednesday 20th November and keep your eyes peeled – more details will be announced soon.
Agenda (more details will be announced soon):
Key nutritional considerations for patients using GLP-1 medications
Obesity medications reduce appetite and “food noise”, giving patients the opportunity to focus on long-term behavioural change and emotional regulation… but what implications does this have for dietary management? In this presentation, dietitian Dr Jess McMaster will cover strategies to support weight loss while maintaining lean muscle mass, developing balanced eating habits, preventing undernutrition and managing side effects. Jess will unpack how dietitians can leverage reduced food-related urges to help their patients manage their emotional response to food, in turn implementing regulation strategies that support long-term, healthy behaviours.
Dr Jess McMaster is an Accredited Practising Dietitian with a focus on metabolic health, weight management and the role of GLP-1 medications in treating obesity and related comorbidities. She earned her PhD from the University of Queensland in 2019, where she examined an endoscopically placed weight loss aid and its impact on the gut. Jess is passionate about empowering patients to manage chronic lifestyle diseases through evidence-based dietary strategies. She brings a wealth of knowledge to her clinical practice, optimising nutrition for individuals using GLP-1 medications and helping them achieve sustainable weight loss and improved metabolic health.
US dietitians: “Obesity medications symposium: what, why, how?” was not Prior Approved by CDR for CPEUs.
CPD/CEU hours are applicable for Australia and New Zealand dietitians. Check your local country requirements to see if you can claim for continuing education.
The content, products and/or services referred to in this symposium are intended for Health Care Professionals only and are not, and are not intended to be, medical advice, which should be tailored to your individual circumstances. The content is for your information only, and we advise that you exercise your own judgement before deciding to use the information provided. Professional medical advice should be obtained before taking action. The reference to particular products and/or services in this symposium does not constitute any form of endorsement. Please see here for terms and conditions.
| Continuing Education (USA) | |
|---|---|
| Duration | 2.5 hours |
| CPEUs Awarded | N/A |
| Performance Indicators | N/A |